MFN Partners Management as of March 31, 2019
Portfolio Holdings for MFN Partners Management
MFN Partners Management holds 15 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 15.3 | $95M | 650k | 146.41 | |
| Fox Corp (FOXA) | 14.0 | $87M | 2.4M | 36.71 | |
| PG&E Corporation (PCG) | 11.5 | $71M | 4.0M | 17.80 | |
| Ironwood Pharmaceuticals (IRWD) | 10.8 | $67M | 4.9M | 13.53 | |
| Cheniere Energy (LNG) | 8.3 | $51M | 750k | 68.36 | |
| Bristol Myers Squibb (BMY) | 7.7 | $48M | 1.0M | 47.71 | |
| Xpo Logistics Inc equity (XPO) | 7.3 | $45M | 846k | 53.74 | |
| Gtt Communications | 5.6 | $35M | 1.0M | 34.70 | |
| Goldman Sachs (GS) | 5.4 | $33M | 174k | 191.99 | |
| Pioneer Natural Resources (PXD) | 4.9 | $31M | 200k | 152.28 | |
| Fgl Holdings | 3.8 | $24M | 3.0M | 7.87 | |
| Takeda Pharmaceutical (TAK) | 2.6 | $16M | 785k | 20.37 | |
| Aclaris Therapeutics (ACRS) | 1.4 | $9.0M | 1.5M | 5.99 | |
| Navient Corporation equity (NAVI) | 1.2 | $7.5M | 650k | 11.57 | |
| Revance Therapeutics (RVNC) | 0.1 | $725k | 46k | 15.76 |
